Skip to Main Content

Paper Details

Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab.
Clin Cancer Res
9
2022
Author NameAffiliation
Fang-Shu OuMayo Clinic
Benjamin G VincentUniversity of North Carolina at Chapel Hill
  • 1 - 2

Datasets

Release 1.2